Cite
HARVARD Citation
Verschueren, P. et al. (2015). Methotrexate in combination with other DMARDs is not superior to methotrexate alone for remission induction with moderate-to-high-dose glucocorticoid bridging in early rheumatoid arthritis after 16 weeks of treatment: the CareRA trial. Annals of the rheumatic diseases. 74 (1), pp. 27-34. [Online].